Literature DB >> 22527649

[Prevalence and predictors of urogenital pain in men. Results from a survey of a representative German population sample].

W Häuser1, G Schmutzer, A Hinz, E Brähler.   

Abstract

BACKGROUND: In Germany no data are available on the prevalence and predictors of urogenital pain in men from representative population samples.
MATERIALS AND METHODS: Persons older than 14 years of age from a representative sample of the German population were examined by standardized questionnaires within a cross-sectional survey. Urogenital pain was assessed by the German version of the National Institutes of Health Chronic Prostatitis Symptoms Index (NIH-CPSI), depression by the patient health questionnaire PHQ-9 and health-related quality of life by the short form health survey SF-36.
RESULTS: A total of 2,043 persons (66.5%s) took part in the study and 960 men with a mean age of 47.2 years were analyzed. The 1-week prevalence of urogenital pain was 9.6% whereby 2.4% met the criteria of mild and 1.9% the criteria of severe prostatitis-like symptoms. The total pain score of the NIH-CPSI was predicted by old age, high income and high depression scores. Men with mild and severe prostatitis-like symptoms reported higher depression and lower health-related quality of life than men without prostatitis-like symptoms
CONCLUSIONS: Prostatitis-like symptoms are associated with depression and reduced health-related quality of life in the general population.

Entities:  

Mesh:

Year:  2012        PMID: 22527649     DOI: 10.1007/s00482-011-1141-1

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  23 in total

Review 1.  The urogenital and rectal pain syndromes.

Authors:  Ursula Wesselmann; Arthur L Burnett; Leslie J Heinberg
Journal:  Pain       Date:  1997-12       Impact factor: 6.961

2.  Prevalence of prostatitis-like symptoms in Japanese men: Population-based study in a town in Hokkaido.

Authors:  Yasuharu Kunishima; Mitsuru Mori; Hiroshi Kitamura; Hiroshi Satoh; Taiji Tsukamoto
Journal:  Int J Urol       Date:  2006-10       Impact factor: 3.369

3.  Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Yanlin Wang; Mark S Litwin; Mary McNaughton-Collins; J Richard Landis; Richard B Alexander; Anthony J Schaeffer; Michael P O'Leary; Michel A Pontari; Jackson E Fowler; Leroy M Nyberg; John W Kusek
Journal:  J Pain       Date:  2006-10       Impact factor: 5.820

4.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

5.  The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.

Authors:  M S Litwin; M McNaughton-Collins; F J Fowler; J C Nickel; E A Calhoun; M A Pontari; R B Alexander; J T Farrar; M P O'Leary
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

6.  How common is prostatitis? A national survey of physician visits.

Authors:  M M Collins; R S Stafford; M P O'Leary; M J Barry
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

7.  The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey.

Authors:  Jim C Hu; Carol L Link; Mary McNaughton-Collins; Michael J Barry; John B McKinlay
Journal:  J Gen Intern Med       Date:  2007-09-01       Impact factor: 5.128

8.  Prevalence of chronic prostatitis symptoms in a randomly surveyed adult population of urban-community-dwelling Nigerian males.

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int J Urol       Date:  2008-04       Impact factor: 3.369

9.  [Prevalence and predictors of pain in several body regions. Results of a representative German population survey].

Authors:  W Häuser; G Schmutzer; H Glaesmer; E Brähler
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

10.  National prevalence of urogenital pain and prostatitis-like symptoms in Australian men using the National Institutes of Health Chronic Prostatitis Symptoms Index.

Authors:  Jason A Ferris; Marian K Pitts; Juliet Richters; Judy M Simpson; Julia M Shelley; Anthony M Smith
Journal:  BJU Int       Date:  2009-06-19       Impact factor: 5.588

View more
  7 in total

Review 1.  [Visceral pain].

Authors:  S Elsenbruch; W Häuser; W Jänig
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

Review 2.  [Chronic pelvic pain].

Authors:  O Moormann; I Gralow
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

3.  [Prevalence of disabling abdominal pain and menstrual cramp. Results from a representative survey of the general German population].

Authors:  W Häuser; G Schmutzer; E Brähler
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

Review 4.  [Pain management in urology].

Authors:  A Zimmer; F Greul; W Meißner
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

5.  [Healthcare services research on pain in Germany. A survey].

Authors:  W Häuser; E Neugebauer; F Petzke
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

6.  Combined Cognitive-Behavioural and Physiotherapeutic Therapy for Patients with Chronic Pelvic Pain Syndrome (COMBI-CPPS): study protocol for a controlled feasibility trial.

Authors:  Christian A Brünahl; Susanne G R Klotz; Christoph Dybowski; Björn Riegel; Sonja Gregorzik; Dean A Tripp; Gesche Ketels; Bernd Löwe
Journal:  Trials       Date:  2018-01-09       Impact factor: 2.279

7.  Investigating Causal Relations between Genetic-Related Intermediate Endophenotype and Risk of Chronic Prostatitis: Mendelian Randomization Study.

Authors:  Shengfeng Zhang; Xing Xie; Lei Yu; Nili Jiang; Xihuan Wei; Yanling Hu
Journal:  Oxid Med Cell Longev       Date:  2022-08-28       Impact factor: 7.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.